IMAGING SPECTRUM OF INTRACRANIAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS: A CROSS-SECTIONAL STUDY FROM A TERTIARY CARE CENTER IN NORTH INDIA
Main Article Content
Keywords
Intracranial infections; Immunocompromised; Neuroimaging; Tuberculoma; Toxoplasmosis; HIV; MRI
Abstract
Background: Intracranial infections are a significant cause of morbidity and mortality in immunocompromised patients, with a wide spectrum of etiological agents and overlapping clinical and radiological features. Early and accurate diagnosis is crucial for effective management, particularly in resource-limited settings.
Objectives: To evaluate the imaging spectrum of intracranial infections in immunocompromised patients and to correlate radiological findings with clinical and demographic parameters.
Methods: This hospital-based cross-sectional observational study was conducted in the Department of Radiodiagnosis at a tertiary care hospital in North India from August 2017 to November 2017. A total of 42 immunocompromised patients with suspected intracranial infections were included using consecutive sampling. Clinical data were recorded using a structured proforma. All patients underwent CT and/or MRI brain imaging. Imaging findings were analyzed for lesion characteristics, distribution, and associated features. Statistical analysis was performed using SPSS version 20.0, with a p-value <0.05 considered significant.
Results: The majority of patients were aged 21–40 years, with a male predominance. HIV infection was the most common immunocompromised state (35.7%). Tuberculoma was the most frequent intracranial infection (33.3%), followed by toxoplasmosis (23.8%) and pyogenic abscess (16.7%). Multiple lesions (59.5%) and ring-enhancing patterns (61.9%) were the most common imaging findings. Perilesional edema was present in 71.4% of cases. A statistically significant association was found between HIV positivity and toxoplasmosis (p < 0.05).
Conclusion: Intracranial infections in immunocompromised patients demonstrate a wide range of imaging patterns, with tuberculoma being the most common in this setting. Neuroimaging plays a pivotal role in diagnosis, and correlation with clinical parameters is essential for optimal patient management.
References
2. Sonneville R, Klein I, De Broucker T, Wolff M. Post-infectious encephalitis in adults: diagnosis and management. Journal of Infection. 2009 May 1;58(5):321-8.
3. Glastonbury CM, Osborn AG, Salzman KL. Masses and malformations of the third ventricle: normal anatomic relationships and differential diagnoses. Radiographics. 2011 Nov;31(7):1889-905.
4. Gupta RK, Kumar S. Central nervous system tuberculosis. Neuroimaging Clinics. 2011 Nov 1;21(4):795-814.
5. Hartmann KM, Golinski M, Reith W. ZNS-Infektionen bei immunsupprimierten Patienten [CNS infections in immunocompromised patients]. Radiologe. 2008 Jun;48(6):560-71. German
6. Lattuada E, Lanzafame M, Concia E, Vento S. Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis. Int J STD AIDS. 2007 Feb;18(2):144-5.
7. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clinical microbiology reviews. 2008 Apr;21(2):243-61.
8. Sharma BS, Khosla VK, Kak VK, Banerjee AK, Vasishtha RK, Prasad KM, Sharma SC, Mathuriya SN, Tewari MK, Pathak A. Intracranial fungal granuloma. Surgical neurology. 1997 May 1;47(5):489-97.
9. Bernaerts A, Vanhoenacker FM, Parizel PM, Van Goethem JW, Van Altena R, Laridon A, De Roeck J, Coeman V, De Schepper AM. Tuberculosis of the central nervous system: overview of neuroradiological findings. European radiology. 2003 Aug;13(8):1876-90.
10. Bernaerts A, Vanhoenacker FM, Parizel PM, Van Goethem JW, Van Altena R, Laridon A, De Roeck J, Coeman V, De Schepper AM. Tuberculosis of the central nervous system: overview of neuroradiological findings. European radiology. 2003 Aug;13(8):1876-90.
11. Van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. New England Journal of Medicine. 2006 Jan 5;354(1):44-53.

